Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...
The biotech sector is one that’s become red-hot, at least in recent years. After around a decade of stagnation, investors ...
If you look at a stock chart mapping the performance of the State Street SPDR S&P Biotech exchange-traded fund since early 2021, it seems to tell a simple story: The biotech sector has been a disaster ...
Something unusual is happening with biotech stocks: They are going up. The SPDR S&P Biotech exchange-traded fund, which tracks a broad selection of biotech names, has shot up 8.9% since September 25, ...
The Biotech industry has underperformed due to the Trump administration, RFK Jr.'s skepticism, and funding uncertainty, with major ETFs down 19-25% over six months. Some biotech companies with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results